GPT and hyperlipidemia: After intraperitoneal injection with UAG, the serum TC and TG levels, as well as ALT, AST concentrations, and hepatic TG decreased significantly (vs hyperlipidemia group, P<0.05 or 0.01, Figures 6A, 6B, and 6C), exhibiting a dose-dependent relationship.